|
1
|
Vecchié A, Dallegri F, Carbone F,
Bonaventura A, Liberale L, Portincasa P, Frühbeck G and Montecucco
F: Obesity phenotypes and their paradoxical association with
cardiovascular diseases. Eur J Intern Med. 48:6–17. 2018.
View Article : Google Scholar
|
|
2
|
Mendez-Sanchez N, Cruz-Ramon VC,
Ramirez-Perez OL, Hwang JP, Barranco-Fragoso B and Cordova-Gallardo
J: New aspects of lipotoxicity in nonalcoholic steatohepatitis. Int
J Mol Sci. 19:2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Listenberger LL, Ostermeyer-Fay AG,
Goldberg EB, Brown WJ and Brown DA: Adipocyte
differentiation-related protein reduces the lipid droplet
association of adipose triglyceride lipase and slows
triacylglycerol turnover. J Lipid Res. 48:2751–2761. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feldstein AE, Werneburg NW, Canbay A,
Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ and Gores GJ: Free
fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha
expression via a lysosomal pathway. Hepatology. 40:185–194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Neuschwander-Tetri BA: Hepatic
lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis:
The central role of nontriglyceride fatty acid metabolites.
Hepatology. 52:774–788. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ter Horst KW and Serlie MJ: Fructose
consumption, lipogenesis, and non-alcoholic fatty liver disease.
Nutrients. 9:pii: E981. 2017.PubMed/NCBI
|
|
7
|
Gnocchi D, Massimi M, Alisi A, Incerpi S
and Bruscalupi G: Effect of fructose and 3,5-diiodothyronine
(3,5-T(2)) on lipid accumulation and insulin signalling in
non-alcoholic fatty liver disease (NAFLD)-like rat primary
hepatocytes. Horm Metab Res. 46:333–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grasselli E, Canesi L, Portincasa P, Voci
A, Vergani L and Demori I: Models of non-alcoholic fatty liver
disease and potential translational value: The effects of
3,5-L-diiodothyronine. Ann Hepatol. 16:707–719. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moore KJ, Rayner KJ, Suárez Y and
Fernández-Hernando C: The role of microRNAs in cholesterol efflux
and hepatic lipid metabolism. Annu Rev Nutr. 31:49–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dongiovanni P, Meroni M, Longo M, Fargion
S and Fracanzani AL: miRNA signature in NAFLD: A turning point for
a non-invasive diagnosis. Int J Mol Sci. 19:2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baselga-Escudero L, Souza-Mello V,
Pascual-Serrano A, Rachid T, Voci A, Demori I and Grasselli E:
Beneficial effects of the Mediterranean spices and aromas on
non-alcoholic fatty liver disease. Trends Food Sci Technol.
61:141–159. 2017. View Article : Google Scholar
|
|
12
|
Loguercio C, Tiso A, Cotticelli G, Blanco
Cdel V, Arpino G, Laringe M, Napoli L, Piccinocchi G, Bonfrate L,
Grattagliano I, et al: Management of chronic liver disease by
general practitioners in southern Italy: Unmet educational needs.
Dig Liver Dis. 43:736–741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loguercio C and Festi D: Silybin and the
liver: From basic research to clinical practice. World J
Gastroenterol. 17:2288–2301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar
|
|
15
|
Wolf BB, Schuler M, Echeverri F and Green
DR: Caspase-3 is the primary activator of apoptotic DNA
fragmentation via DNA fragmentation factor-45/inhibitor of
caspase-activated DNase inactivation. J Biol Chem. 274:30651–30656.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wiechelman KJ, Braun RD and Fitzpatrick
JD: Investigation of the bicinchoninic acid protein assay:
Identification of the groups responsible for color formation. Anal
Biochem. 175:231–237. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moreira AC, Branco AF, Sampaio SF,
Cunha-Oliveira T, Martins TR, Holy J, Oliveira PJ and Sardão VA:
Mitochondrial apoptosis-inducing factor is involved in
doxorubicin-induced toxicity on H9c2 cardiomyoblasts. Biochim
Biophys Acta. 1842:2468–2478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grasselli E, Voci A, Canesi L, Goglia F,
Ravera S, Panfoli I, Gallo G and Vergani L: Non-receptor-mediated
actions are responsible for the lipid-lowering effects of
iodothyronines in FaO rat hepatoma cells. J Endocrinol. 210:59–69.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grasselli E, Voci A, Pesce C, Canesi L,
Fugassa E, Gallo G and Vergani L: PAT protein mRNA expression in
primary rat hepatocytes: Effects of exposure to fatty acids. Int J
Mol Med. 25:505–512. 2010.PubMed/NCBI
|
|
20
|
Goodridge AG: Regulation of the activity
of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and
citrate. J Biol Chem. 247:6946–6952. 1972.PubMed/NCBI
|
|
21
|
Vecchione G, Grasselli E, Voci A, Baldini
F, Grattagliano I, Wang DQ, Portincasa P and Vergani L: Silybin
counteracts lipid excess and oxidative stress in cultured steatotic
hepatic cells. World J Gastroenterol. 22:6016–6026. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iguchi H, Kojo S and Ikeda M: Lipid
peroxidation and disintegration of the cell membrane structure in
cultures of rat lung fibroblasts treated with asbestos. J Appl
Toxicol. 13:269–275. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Vecchione G, Grasselli E, Cioffi F,
Baldini F, Oliveira PJ, Sardão VA, Cortese K, Lanni A, Voci A,
Portincasa P and Vergani L: The nutraceutic silybin counteracts
excess lipid accumulation and ongoing oxidative stress in an in
vitro model of non-alcoholic fatty liver disease progression. Front
Nutr. 4:422017. View Article : Google Scholar :
|
|
26
|
Deus CM, Zehowski C, Nordgren K, Wallace
KB, Skildum A and Oliveira PJ: Stimulating basal mitochondrial
respiration decreases doxorubicin apoptotic signaling in H9c2
cardiomyo-blasts. Toxicology. 334:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hudgins LC, Parker TS, Levine DM and
Hellerstein MK: A dual sugar challenge test for lipogenic
sensitivity to dietary fructose. J Clin Endocrinol Metab.
96:861–868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tetri LH, Basaranoglu M, Brunt EM, Yerian
LM and Neuschwander-Tetri BA: Severe NAFLD with hepatic
necroinflammatory changes in mice fed trans fats and a
high-fructose corn syrup equivalent. Am J Physiol Gastrointest
Liver Physiol. 295:G987–G995. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reina M and Martinez A: Silybin and
2,3-dehydrosilybin flavonolignans as free radical scavengers. J
Phys Chem B. 119:11597–11606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosso N, Marin V, Giordani A, Persiani S,
Sala F, Cavicchioli L, Rovati LC and Tiribelli C: The pros and the
cons for the use of silybin-rich oral formulations in treatment of
liver damage (NAFLD in particular). Curr Med Chem. 22:2954–2971.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ameer F, Scandiuzzi L, Hasnain S,
Kalbacher H and Zaidi N: De novo lipogenesis in health and disease.
Metabolism. 63:895–902. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abenavoli L, Greco M, Nazionale I, Peta V,
Milic N, Accattato F, Foti D, Gulletta E and Luzza F: Effects of
Mediterranean diet supplemented with silybin-vitamin E-phospholipid
complex in overweight patients with non-alcoholic fatty liver
disease. Expert Rev Gastroenterol Hepatol. 9:519–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Federico A, Conti V, Russomanno G, Dallio
M, Masarone M, Stiuso P, Tuccillo C, Caraglia M, Manzo V, Persico
M, et al: A long-term treatment with silybin in patients with
non-alcoholic steatohepatitis stimulates catalase activity in human
endothelial cells. In Vivo. 31:609–618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wah Kheong C, Nik Mustapha NR and Mahadeva
S: A randomized trial of silymarin for the treatment of
nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol.
15:1940–1949.e8. 2017. View Article : Google Scholar
|
|
35
|
Satapati S, Kucejova B, Duarte JA,
Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu
X, et al: Mitochondrial metabolism mediates oxidative stress and
inflammation in fatty liver. J Clin Invest. 125:4447–4462. 2015.
View Article : Google Scholar : PubMed/NCBI
|
